Compounding Pharmacies Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Compounding Pharmacies Market to 2027 - Global Analysis and Forecasts By Product (Oral Medications, Topical Medications, Suppositories, Others); Therapeutic Area (Pain Medications, Hormone Replacement Therapies, Dermatological Applications, Others)

Report Code: TIPRE00005407 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
The science of combining and preparing personalized medicines for patients is termed as compounding. These medicines are prepared based on practitioners' prescription wherein, the individual ingredients are mixed together as per the suggested dosage form and strength.

MARKET DYNAMICS
The Compounding Pharmacies market is anticipated to grow in the forecast, owing to the factors such as rising patent expiry, rise in geriatric population, increase in the number of dispensed prescriptions, and public demand for compounding drugs. Nevertheless, lack of efficient regulations in various regions is expected to hamper the growth of the market during the forecast period.

MARKET SCOPE
The "Global Compounding Pharmacies Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Compounding Pharmacies market with detailed market segmentation by product, therapeutic area, and geography. The global Compounding Pharmacies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Compounding Pharmacies market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Compounding Pharmacies market is segmented on the basis of product and therapeutic . Based on product the market is segmented into oral medications, topical medications, suppositories, others. Based on therapeutic area the market is segmented into pain medications, hormone replacement therapies, dermatological applications, others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Compounding Pharmacies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Compounding Pharmacies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Compounding Pharmacies market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Compounding Pharmacies market in these regions.

MARKET PLAYERS
The reports cover key developments in the Compounding Pharmacies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Compounding Pharmacies market are anticipated to lucrative growth opportunities in the future with the rising demand for Compounding Pharmacies market in the global market. Below mentioned is the list of few companies engaged in the Compounding Pharmacies market.

The report also includes the profiles of Compounding Pharmacies market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Fagron
  • Triangle Compounding Pharmacy
  • Institutional Pharmacy Solutions, LLC
  • B. Braun Melsungen AG
  • PharMEDium Services LLC
  • Fresenius Kabi AG
  • Avella Specialty Pharmacy
  • Hoye's Pharmacy
  • Vertisis Custom Pharmacy
  • Clinigen Group plc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Compounding Pharmacies Market - By Product
1.3.2 Compounding Pharmacies Market - By Therapeutic
1.3.3 Compounding Pharmacies Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. COMPOUNDING PHARMACIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. COMPOUNDING PHARMACIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. COMPOUNDING PHARMACIES MARKET - GLOBAL MARKET ANALYSIS
6.1. COMPOUNDING PHARMACIES - GLOBAL MARKET OVERVIEW
6.2. COMPOUNDING PHARMACIES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. COMPOUNDING PHARMACIES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ORAL MEDICATIONS
7.3.1. Overview
7.3.2. Oral Medications Market Forecast and Analysis
7.4. TOPICAL MEDICATIONS
7.4.1. Overview
7.4.2. Topical Medications Market Forecast and Analysis
7.5. SUPPOSITORIES
7.5.1. Overview
7.5.2. Suppositories Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. COMPOUNDING PHARMACIES MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTIC
8.1. OVERVIEW
8.2. THERAPEUTIC MARKET FORECASTS AND ANALYSIS
8.3. PAIN MEDICATIONS
8.3.1. Overview
8.3.2. Pain Medications Market Forecast and Analysis
8.4. HORMONE REPLACEMENT THERAPIES
8.4.1. Overview
8.4.2. Hormone Replacement Therapies Market Forecast and Analysis
8.5. DERMATOLOGICAL APPLICATIONS
8.5.1. Overview
8.5.2. Dermatological Applications Market Forecast and Analysis
8.6. OTHERS.
8.6.1. Overview
8.6.2. Others. Market Forecast and Analysis
9. COMPOUNDING PHARMACIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Compounding Pharmacies Market Overview
9.1.2 North America Compounding Pharmacies Market Forecasts and Analysis
9.1.3 North America Compounding Pharmacies Market Forecasts and Analysis - By Product
9.1.4 North America Compounding Pharmacies Market Forecasts and Analysis - By Therapeutic
9.1.5 North America Compounding Pharmacies Market Forecasts and Analysis - By Countries
9.1.5.1 United States Compounding Pharmacies Market
9.1.5.1.1 United States Compounding Pharmacies Market by Product
9.1.5.1.2 United States Compounding Pharmacies Market by Therapeutic
9.1.5.2 Canada Compounding Pharmacies Market
9.1.5.2.1 Canada Compounding Pharmacies Market by Product
9.1.5.2.2 Canada Compounding Pharmacies Market by Therapeutic
9.1.5.3 Mexico Compounding Pharmacies Market
9.1.5.3.1 Mexico Compounding Pharmacies Market by Product
9.1.5.3.2 Mexico Compounding Pharmacies Market by Therapeutic
9.2. EUROPE
9.2.1 Europe Compounding Pharmacies Market Overview
9.2.2 Europe Compounding Pharmacies Market Forecasts and Analysis
9.2.3 Europe Compounding Pharmacies Market Forecasts and Analysis - By Product
9.2.4 Europe Compounding Pharmacies Market Forecasts and Analysis - By Therapeutic
9.2.5 Europe Compounding Pharmacies Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Compounding Pharmacies Market
9.2.5.1.1 Germany Compounding Pharmacies Market by Product
9.2.5.1.2 Germany Compounding Pharmacies Market by Therapeutic
9.2.5.2 France Compounding Pharmacies Market
9.2.5.2.1 France Compounding Pharmacies Market by Product
9.2.5.2.2 France Compounding Pharmacies Market by Therapeutic
9.2.5.3 Italy Compounding Pharmacies Market
9.2.5.3.1 Italy Compounding Pharmacies Market by Product
9.2.5.3.2 Italy Compounding Pharmacies Market by Therapeutic
9.2.5.4 Spain Compounding Pharmacies Market
9.2.5.4.1 Spain Compounding Pharmacies Market by Product
9.2.5.4.2 Spain Compounding Pharmacies Market by Therapeutic
9.2.5.5 United Kingdom Compounding Pharmacies Market
9.2.5.5.1 United Kingdom Compounding Pharmacies Market by Product
9.2.5.5.2 United Kingdom Compounding Pharmacies Market by Therapeutic
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Compounding Pharmacies Market Overview
9.3.2 Asia-Pacific Compounding Pharmacies Market Forecasts and Analysis
9.3.3 Asia-Pacific Compounding Pharmacies Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Compounding Pharmacies Market Forecasts and Analysis - By Therapeutic
9.3.5 Asia-Pacific Compounding Pharmacies Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Compounding Pharmacies Market
9.3.5.1.1 Australia Compounding Pharmacies Market by Product
9.3.5.1.2 Australia Compounding Pharmacies Market by Therapeutic
9.3.5.2 China Compounding Pharmacies Market
9.3.5.2.1 China Compounding Pharmacies Market by Product
9.3.5.2.2 China Compounding Pharmacies Market by Therapeutic
9.3.5.3 India Compounding Pharmacies Market
9.3.5.3.1 India Compounding Pharmacies Market by Product
9.3.5.3.2 India Compounding Pharmacies Market by Therapeutic
9.3.5.4 Japan Compounding Pharmacies Market
9.3.5.4.1 Japan Compounding Pharmacies Market by Product
9.3.5.4.2 Japan Compounding Pharmacies Market by Therapeutic
9.3.5.5 South Korea Compounding Pharmacies Market
9.3.5.5.1 South Korea Compounding Pharmacies Market by Product
9.3.5.5.2 South Korea Compounding Pharmacies Market by Therapeutic
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Compounding Pharmacies Market Overview
9.4.2 Middle East and Africa Compounding Pharmacies Market Forecasts and Analysis
9.4.3 Middle East and Africa Compounding Pharmacies Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Compounding Pharmacies Market Forecasts and Analysis - By Therapeutic
9.4.5 Middle East and Africa Compounding Pharmacies Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Compounding Pharmacies Market
9.4.5.1.1 South Africa Compounding Pharmacies Market by Product
9.4.5.1.2 South Africa Compounding Pharmacies Market by Therapeutic
9.4.5.2 Saudi Arabia Compounding Pharmacies Market
9.4.5.2.1 Saudi Arabia Compounding Pharmacies Market by Product
9.4.5.2.2 Saudi Arabia Compounding Pharmacies Market by Therapeutic
9.4.5.3 U.A.E Compounding Pharmacies Market
9.4.5.3.1 U.A.E Compounding Pharmacies Market by Product
9.4.5.3.2 U.A.E Compounding Pharmacies Market by Therapeutic
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Compounding Pharmacies Market Overview
9.5.2 South and Central America Compounding Pharmacies Market Forecasts and Analysis
9.5.3 South and Central America Compounding Pharmacies Market Forecasts and Analysis - By Product
9.5.4 South and Central America Compounding Pharmacies Market Forecasts and Analysis - By Therapeutic
9.5.5 South and Central America Compounding Pharmacies Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Compounding Pharmacies Market
9.5.5.1.1 Brazil Compounding Pharmacies Market by Product
9.5.5.1.2 Brazil Compounding Pharmacies Market by Therapeutic
9.5.5.2 Argentina Compounding Pharmacies Market
9.5.5.2.1 Argentina Compounding Pharmacies Market by Product
9.5.5.2.2 Argentina Compounding Pharmacies Market by Therapeutic
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. COMPOUNDING PHARMACIES MARKET, KEY COMPANY PROFILES
11.1. FAGRON
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. TRIANGLE COMPOUNDING PHARMACY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. INSTITUTIONAL PHARMACY SOLUTIONS, LLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. B. BRAUN MELSUNGEN AG
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. PHARMEDIUM SERVICES LLC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. FRESENIUS KABI AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. AVELLA SPECIALTY PHARMACY
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. HOYE'S PHARMACY
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. VERTISIS CUSTOM PHARMACY
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CLINIGEN GROUP PLC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Fagron
- Triangle Compounding Pharmacy
- Institutional Pharmacy Solutions, LLC
- B. Braun Melsungen AG
- PharMEDium Services LLC
- Fresenius Kabi AG
- Avella Specialty Pharmacy
- Hoye's Pharmacy
- Vertisis Custom Pharmacy
- Clinigen Group plc
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book